Location: Home
  • search
  • go
  • Relate News
  • 3/27/2018Agena and Simcere Announce Strategic Partnership for Companion Diagnos...
  • 3/27/2018Novartis CEO Eyes Sharp China Growth on Faster New Drug Approvals
  • 3/26/2018Nicholas Hall Reports 6% Growth for Chinese OTC VMS Market in 2017
  • 3/23/2018Recent Executive Moves
  • 3/23/2018CBT Pharma Licenses CrownBio's CTLA-4 Antibody to Grow Immuno-Oncology...
  • 3/22/2018Allergan Launches RVO Drug Ozurdex in China
  • 3/22/2018Data Snaphot: Chinese Foreign Trade of Medicines and Health Products i...
  • 3/22/2018SemaThera Enters Licensing Deal with Senju Pharma for China and Japan
  • 3/22/2018WuXi Biologics To Install Industry's Largest Single-Use Bioreactor At ...
  • 3/22/2018Promised Import Tariff Reduction on Cancer Drugs by China Expected to ...
  • 3/21/2018China Appoints Key Leaders of State Market Regulatory Administration
  • 3/20/2018Central Government Issues New Document to Deepen Overall Reform of Pub...
  • 3/20/2018Dova Licenses China Rights of Novel Thrombopoietin Receptor Agonist to...
  • 3/16/2018CFDA Issues Pharmaceutical Research Guidance for Phase III Trials of I...
  • 3/16/2018The New Boss on the Block: State Medical Insurance Administration (SMI...
  • 3/15/2018Recent Official and Executive Moves
  • 3/15/2018CFDA Issues Technical Guidelines for Genotoxicity Study of Drugs
  • 3/15/2018China's Fibromyalgia Market Projected To Grow 18.7% CAGR Till 2022
  • 3/14/2018CFDA Seeks Comments on Matters Related to Custom Clearance of APIs and...
  • 3/13/2018United Biopharma Boosts China Presence with New Biologic Facility in Y...
  • 3/13/2018China Prepares for Big Pharma
  • 3/13/2018China Reshuffles Central Government, Overhauling Healthcare, BMI and D...
  • 3/13/2018CDE Solicits Comments for Proposed Technical Guidance Documents
  • 3/13/2018Chi-Med On Its Way for First Drug Approval in China This Year
  • 3/13/2018Hua Medicine Plans $400M Hong Kong IPO
  • 3/12/2018Recent Executive Moves
  • 3/12/2018CDE Seeks Feedbacks on Draft Rules for of Drug R&D and Evaluat...
  • 3/9/2018Chinese CAR-T JV of Wuxi AppTec-Juno Raises $90M in Series A Round
  • 3/9/2018WuXi Biologics and Adagene Enter Strategic Partnership of New Antibody...
  • 3/9/2018Chi-Med Initiates a Phase Ib/II Proof-of-Concept Trial of Epitinib in ...
  • Page:170/361 Total number of articles:10805: [First][<<] [168] [169] [170] [171] [172] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group